In 1998 my friend Brian Sullivan served as the chairman of our state Republican Party’s platform committee. I think Brian appointed John Hinderaker and me committee members. We wrote the audacious platform that Brian assured us he would get approved at the party convention, as he did. We have been friends for a long time.
In his current business venture, Brian is the founder and chief executive officer of Celcuity, a company whose market capitalization is now over $4.6 billion. In successful clinical trials, Celcuity’s product holds the promise of alleviating suffering and extending the lives of women struggling with certain forms of advanced breast cancer. The product is called Gedatolisib. The company announced submission of its new drug application for Gedatolisib to the FDA in a November 2025 press release.
Looking back on 2025, the Star Tribune noted that Celcuity was the runaway winner among Minnesota-based public company stocks in 2025: “In total, the stock is up 663% this year as of its close on Dec. 30 of $99.92.” The stock of the second-place company was up 70.8%.
From chairman of the 1998 Minnesota GOP platform committee Brian has gone on to great things. I only want to take the liberty of congratulating him and wishing Celcuity continued success on its path.
